1. Home
  2. ASRT vs OCCI Comparison

ASRT vs OCCI Comparison

Compare ASRT & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • OCCI
  • Stock Information
  • Founded
  • ASRT 1995
  • OCCI N/A
  • Country
  • ASRT United States
  • OCCI United States
  • Employees
  • ASRT N/A
  • OCCI N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • OCCI Trusts Except Educational Religious and Charitable
  • Sector
  • ASRT Health Care
  • OCCI Finance
  • Exchange
  • ASRT Nasdaq
  • OCCI Nasdaq
  • Market Cap
  • ASRT 84.6M
  • OCCI 146.7M
  • IPO Year
  • ASRT 1997
  • OCCI N/A
  • Fundamental
  • Price
  • ASRT $0.89
  • OCCI $7.09
  • Analyst Decision
  • ASRT Strong Buy
  • OCCI
  • Analyst Count
  • ASRT 4
  • OCCI 0
  • Target Price
  • ASRT $3.19
  • OCCI N/A
  • AVG Volume (30 Days)
  • ASRT 933.9K
  • OCCI 115.8K
  • Earning Date
  • ASRT 11-11-2024
  • OCCI 12-11-2023
  • Dividend Yield
  • ASRT N/A
  • OCCI 24.32%
  • EPS Growth
  • ASRT N/A
  • OCCI N/A
  • EPS
  • ASRT N/A
  • OCCI N/A
  • Revenue
  • ASRT $125,763,000.00
  • OCCI N/A
  • Revenue This Year
  • ASRT N/A
  • OCCI N/A
  • Revenue Next Year
  • ASRT $1.84
  • OCCI $10.19
  • P/E Ratio
  • ASRT N/A
  • OCCI N/A
  • Revenue Growth
  • ASRT N/A
  • OCCI N/A
  • 52 Week Low
  • ASRT $0.73
  • OCCI $5.47
  • 52 Week High
  • ASRT $1.80
  • OCCI $10.15
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 42.24
  • OCCI 38.00
  • Support Level
  • ASRT $0.90
  • OCCI $7.42
  • Resistance Level
  • ASRT $1.04
  • OCCI $7.58
  • Average True Range (ATR)
  • ASRT 0.07
  • OCCI 0.12
  • MACD
  • ASRT -0.01
  • OCCI -0.03
  • Stochastic Oscillator
  • ASRT 28.11
  • OCCI 13.16

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

Share on Social Networks: